Abstract
Neural cancer is among the most aggressive and difficult-to-treat malignancies. There are over 100 subtypes of brain tumors, which make this type of malignancy even more important. Glioblastoma (GBM) is the most important group among them. It is associated with a high rate of mortality. Due to some difficulties to reach the tumor for surgeons and inefficient penetration of medical therapies into the blood-brain barrier, it is critical to have some more effective and specific treatments for those patients. One approach could be targeting the signaling pathways which are involved in this type of cancer. Most of these pathways are essential for regular proliferation and differentiation of cells; however, due to some mutations in one or some of the downstream proteins in the pathways, they become out of control, which leads to uncontrolled cell proliferation. Additionally, some proteins of these pathways could interact with each other through different mechanisms. For example, Naked cuticle 1 (NKD1) acts as a negative regulator of the Wnt signaling pathway. In this chapter, we have covered the most important signaling pathways involved in neural cancers, including Wnt-related signaling cascades which is a key cascade regulating development, pathways related to tumor suppressors (e.g., p53), those associated with proto-oncogenes (e.g., PI3K/Akt Signaling), NF-kB-related pathways, as well as JAK-STAT signaling cascades.
This is a preview of subscription content, log in via an institution to check access.
References
Aasen SN, Parajuli H, Hoang T et al (2019) Effective treatment of metastatic melanoma by combining mapk and pi3k signaling pathway inhibitors. Int J Mol Sci 20. https://doi.org/10.3390/ijms20174235
Ahmed AA, Mohamed AD, Gener M et al (2017) YAP and the Hippo pathway in pediatric cancer. Mol Cell Oncol 4:e1295127
Ahmed M, Lorence E, Wang J et al (2019) Interrogating B cell signaling pathways: a quest for novel therapies for mantle cell lymphoma. Sci Signal 12:eaat4105
Ahn HY, Hadizadeh KR, Seul C et al (1999) Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172). Mol Biol Cell 10:1093–1104. https://doi.org/10.1091/mbc.10.4.1093
Anne SL, Govek E-E, Ayrault O et al (2013) WNT3 inhibits cerebellar granule neuron progenitor proliferation and medulloblastoma formation via MAPK activation. PLoS One 8:e81769. https://doi.org/10.1371/journal.pone.0081769
Arend RC, Londoño-Joshi AI, Straughn JM, Buchsbaum DJ (2013) The Wnt/β-catenin pathway in ovarian cancer: a review. Gynecol Oncol 131:772–779. https://doi.org/10.1016/j.ygyno.2013.09.034
Ashcroft M, Vousden KH (1999) Regulation of p53 stability. Oncogene 18:7637–7643. https://doi.org/10.1038/sj.onc.1203012
Avelino KYPS, Oliveira LS, de Oliveira HP et al (2022) Impedimetric sensing platform for human papillomavirus and p53 tumor suppressor gene in cervical samples. J Sci Adv Mater Dev 7:100411. https://doi.org/10.1016/j.jsamd.2021.100411
Azatyan A, Gallo-Oller G, Diao Y et al (2019) RITA downregulates Hedgehog-GLI in medulloblastoma and rhabdomyosarcoma via JNK-dependent but p53-independent mechanism. Cancer Lett 442:341–350. https://doi.org/10.1016/j.canlet.2018.11.005
Bang J, Han M, Yoo TJ et al (2021) Identification of signaling pathways for early embryonic lethality and developmental retardation in sephs1−/− mice. Int J Mol Sci 22:11647. https://doi.org/10.3390/ijms222111647
Bazrafkan M, Hosseini E, Nazari M et al (2021) NLRP3 inflammasome: a joint, potential therapeutic target in management of COVID-19 and fertility problems. J Reprod Immunol 148. https://doi.org/10.1016/j.jri.2021.103427
Belcher SM, Ma X, Le HH (2009) Blockade of estrogen receptor signaling inhibits growth and migration of medulloblastoma. Endocrinology 150:1112–1121. https://doi.org/10.1210/en.2008-1363
Bénard J, Douc-Rasy S, Ahomadegbe JC (2003) TP53 family members and human cancers. Hum Mutat 21:182–191. https://doi.org/10.1002/humu.10172
Ben-Ze’ev A, Basu S, Haase G (2016) Wnt signaling in cancer stem cells and colon cancer metastasis. F1000Res 5. https://doi.org/10.12688/f1000research.7579.1
Beschorner R, Waidelich J, Trautmann K et al (2013) Notch receptors in human choroid plexus tumors. Histol Histopathol 28:1055–1063. https://doi.org/10.14670/HH-28.1055
Bhatia B, Malik A, Fernandez-L A, Kenney AM (2010) p27(Kip1), a double-edged sword in Shh-mediated medulloblastoma: tumor accelerator and suppressor. Cell cycle (Georgetown, Tex) 9:4307–4314. https://doi.org/10.4161/cc.9.21.13441
Bi Y, Zhu Y, Zhang M et al (2017) Effect of shikonin on spinal cord injury in rats via regulation of HMGB1/TLR4/NF-κB signaling pathway. Cell Physiol Biochem 43:481–491. https://doi.org/10.1159/000480474
Binart N, Ormandy CJ, Kelly PA (2000) Mammary gland development and the prolactin receptor. Adv Exp Med Biol 480:85–92. https://doi.org/10.1007/0-306-46832-8_10
Blazquez R, Wlochowitz D, Wolff A et al (2018) PI3K: a master regulator of brain metastasis-promoting macrophages/microglia. Glia 66:2438–2455. https://doi.org/10.1002/glia.23485
Boer K, Troost D, Timmermans W et al (2010) Pi3K-mTOR signaling and AMOG expression in epilepsy-associated glioneuronal tumors. Brain Pathol (Zurich, Switzerland) 20:234–244. https://doi.org/10.1111/j.1750-3639.2009.00268.x
Bonham PA (2009) Swab cultures for diagnosing wound infections: a literature review and clinical guideline. J Wound Ostomy Continence Nurs 36:389–395. https://doi.org/10.1097/WON.0b013e3181aaef7f
Bousoik E, Montazeri Aliabadi H (2018) “Do we know Jack” about JAK? A closer look at JAK/STAT signaling pathway. Front Oncol 8. https://doi.org/10.3389/fonc.2018.00287
Brennan C (2011) Genomic profiles of glioma. Curr Neurol Neurosci Rep 11:291–297. https://doi.org/10.1007/s11910-011-0198-7
Bryukhovetskiy I, Shevchenko V (2016) Molecular mechanisms of the effect of TGF-β1 on U87 human glioblastoma cells. Oncol Lett 12:1581–1590. https://doi.org/10.3892/ol.2016.4756
Bugter JM, Fenderico N, Maurice MM (2021) Mutations and mechanisms of WNT pathway tumour suppressors in cancer. Nat Rev Cancer 21:5–21. https://doi.org/10.1038/s41568-020-00307-z
Buitenhuis M, Coffer PJ, Koenderman L (2004) Signal transducer and activator of transcription 5 (STAT5). Int J Biochem Cell Biol 36:2120–2124. https://doi.org/10.1016/j.biocel.2003.11.008
Busch-Dienstfertig M, González-Rodríguez S (2013) IL-4, JAK-STAT signaling, and pain. Jak-Stat 2:e27638. https://doi.org/10.4161/jkst.27638
Cai H, Liu X, Zheng J et al (2017) Long non-coding RNA taurine upregulated 1 enhances tumor-induced angiogenesis through inhibiting microRNA-299 in human glioblastoma. Oncogene 36:318–331. https://doi.org/10.1038/onc.2016.212
Cai Y, Chen K, Cheng C et al (2020) Prp19 is an independent prognostic marker and promotes neuroblastoma metastasis by regulating the Hippo-YAP signaling pathway. Front Oncol 10:1872. https://doi.org/10.3389/fonc.2020.575366
Cao L, Li R, Chen X et al (2016) Neougonin a inhibits lipopolysaccharide-induced inflammatory responses via downregulation of the NF-kB Signaling pathway in RAW 264.7 macrophages. Inflammation 39:1939–1948. https://doi.org/10.1007/s10753-016-0429-9
Carballo GB, Honorato JR, De Lopes GPF, Spohr TCLDSE (2018) A highlight on Sonic hedgehog pathway. Cell Commun Signal 16. https://doi.org/10.1186/s12964-018-0220-7
Carroll RS, Black PM, Zhang J et al (1997) Expression and activation of epidermal growth factor receptors in meningiomas. J Neurosurg 87:315–323. https://doi.org/10.3171/jns.1997.87.2.0315
Casati G, Giunti L, Iorio AL et al (2021) Hippo pathway in regulating drug resistance of glioblastoma. Int J Mol Sci 22:13431. https://doi.org/10.3390/ijms222413431
Chakravarti A, Dicker A, Mehta M (2004) The contribution of epidermal growth factor receptor (EGFR) signaling pathway to radioresistance in human gliomas: a review of preclinical and correlative clinical data. Int J Radiat Oncol Biol Phys 58:927–931. https://doi.org/10.1016/j.ijrobp.2003.09.092
Chen J-N, Yiang G-T, Lin Y-F et al (2015a) Rana catesbeiana ribonuclease induces cell apoptosis via the caspase-9/−3 signaling pathway in human glioblastoma DBTRG, GBM8901 and GBM8401 cell lines. Oncol Lett 9:2471–2476. https://doi.org/10.3892/ol.2015.3117
Chen XH, Ling XM, Shi S (2015b) microRNA-106a induces the proliferation and apoptosis of glioma cells through regulating JNK/MAPK pathway. Eur Rev Med Pharmacol Sci 19:3412–3417
Chen T, Chen J, Zhu Y et al (2019) CD163, a novel therapeutic target, regulates the proliferation and stemness of glioma cells via casein kinase 2. Oncogene 38:1183–1199. https://doi.org/10.1038/s41388-018-0515-6
Chen Y, Fang R, Yue C et al (2020) Wnt-induced stabilization of KDM4C is required for Wnt/β-catenin target gene expression and glioblastoma tumorigenesis. Cancer Res 80:1049–1063. https://doi.org/10.1158/0008-5472.CAN-19-1229
Chen Y, Gao H, Xie W et al (2021) Genomic and transcriptomic analysis of pituitary adenomas reveals the impacts of copy number variations on gene expression and clinical prognosis among prolactin-secreting subtype. Aging 13:1276–1293. https://doi.org/10.18632/aging.202304
Cheng S-Q, Fan H-Y, Xu X et al (2016) Over-expression of LRIG1 suppresses biological function of pituitary adenoma via attenuation of PI3K/AKT and Ras/Raf/ERK pathways in vivo and in vitro. J Huazhong Univ Sci Technol Med Sci = Hua zhong ke ji da xue xue bao Yi xue Ying De wen ban = Huazhong keji daxue xuebao Yixue Yingdewen ban 36:558–563. https://doi.org/10.1007/s11596-016-1625-4
Chiurillo MA (2015) Role of the Wnt/β-catenin pathway in gastric cancer: an in-depth literature review. World J Exp Med 5:84. https://doi.org/10.5493/wjem.v5.i2.84
Chumakov PM (2007) Versatile functions of p53 protein in multicellular organisms. Biochemistry (Moscow) 72:1399–1421. https://doi.org/10.1134/S0006297907130019
Chung SK, Wang KC, Nam DH, Cho BK (1998) Brain tumor in the first year of life: a single institute study. J Korean Med Sci 13:65–70. https://doi.org/10.3346/jkms.1998.13.1.65
Cohen JV, Sullivan RJ (2019) Developments in the space of new MAPK pathway inhibitors for BRAF-mutant melanoma. Clin Cancer Res 25:5735–5742. https://doi.org/10.1158/1078-0432.CCR-18-0836
Cong P, Hou HY, Wei W et al (2020) MiR-920 and LSP1 co-regulate the growth and migration of glioblastoma cells by modulation of JAK2/STAT5 pathway. J Bioenerg Biomembr 52:311–320. https://doi.org/10.1007/s10863-020-09848-2
Creagh EM, O’Neill LAJ (2006) TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol 27:352–357. https://doi.org/10.1016/j.it.2006.06.003
Cuevas IC, Slocum AL, Jun P et al (2005) Meningioma transcript profiles reveal deregulated Notch signaling pathway. Cancer Res 65:5070–5075. https://doi.org/10.1158/0008-5472.CAN-05-0240
D’Alessandro G, Quaglio D, Monaco L et al (2019) 1H-NMR metabolomics reveals the Glabrescione B exacerbation of glycolytic metabolism beside the cell growth inhibitory effect in glioma. Cell Commun Signal 17:1–12. https://doi.org/10.1186/s12964-019-0421-8
Dahlin AM, Hollegaard MV, Wibom C et al (2015) CCND2, CTNNB1, DDX3X, GLI2, SMARCA4, MYC, MYCN, PTCH1, TP53, and MLL2 gene variants and risk of childhood medulloblastoma. J Neuro-Oncol 125:75–78. https://doi.org/10.1007/s11060-015-1891-1
Daly CA, Hall ET, Ogden SK (2022) Regulatory mechanisms of cytoneme-based morphogen transport. Cell Mol Life Sci 79:1–20. https://doi.org/10.1007/s00018-022-04148-x
Das H, Kumar A, Lin Z et al (2006) Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes. Proc Natl Acad Sci U S A 103:6653–6658. https://doi.org/10.1073/pnas.0508235103
Dawson JC, Serrels A, Stupack DG et al (2021) Targeting FAK in anticancer combination therapies. Nat Rev Cancer 21:313–324. https://doi.org/10.1038/s41568-021-00340-6
De Vleeschouwer S (2017) Glioblastoma [Internet]. Codon Publications
Dekker RJ, Boon RA, Rondaij MG et al (2006) KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium. Blood 107:4354–4363. https://doi.org/10.1182/blood-2005-08-3465
Deogharkar A, Singh SV, Bharambe HS et al (2021) Downregulation of ARID1B, a tumor suppressor in the WNT subgroup medulloblastoma, activates multiple oncogenic signaling pathways. Hum Mol Genet 30:1721–1733. https://doi.org/10.1093/hmg/ddab134
Derry SW (2012) Calcium induced Naked1 activity in Wnt signaling
Dhillon AS, Hagan S, Rath O, Kolch W (2007) MAP kinase signalling pathways in cancer. Oncogene 26:3279–3290. https://doi.org/10.1038/sj.onc.1210421
Dimitrova V, Arcaro A (2015) Targeting the PI3K/AKT/mTOR signaling pathway in medulloblastoma. Curr Mol Med 15:82–93. https://doi.org/10.2174/1566524015666150114115427
Ding H, Cui L, Wang C (2021) Long noncoding RNA LIFR-AS1 suppresses proliferation, migration and invasion and promotes apoptosis through modulating miR-4262/NF-κB pathway in glioma. Neurol Res 43:210–219. https://doi.org/10.1080/01616412.2020.1836465
Dolcet X, Llobet D, Pallares J, Matias-Guiu X (2005) NF-kB in development and progression of human cancer. Virchows Arch 446:475–482. https://doi.org/10.1007/s00428-005-1264-9
Dong C, Mi R, Jin G et al (2015) Identification of the proliferative effect of Smad2 and 3 in the TGF β2/Smad signaling pathway using RNA interference in a glioma cell line. Mol Med Rep 12:1824–1828. https://doi.org/10.3892/mmr.2015.3614
Dong M, Xiao Q, Hu J et al (2020) Targeting LRIG2 overcomes resistance to EGFR inhibitor in glioblastoma by modulating GAS6/AXL/SRC signaling. Cancer Gene Ther 27:878–897. https://doi.org/10.1038/s41417-020-0163-1
Dong C, Li X, Yang J et al (2021) PPFIBP1 induces glioma cell migration and invasion through FAK/Src/JNK signaling pathway. Cell Death Dis 12:827. https://doi.org/10.1038/s41419-021-04107-7
Dougherty K, Mannell M, Naqvi O et al (2021) SARS-CoV-2 B.1.617.2 (delta) variant COVID-19 outbreak associated with a gymnastics facility — Oklahoma, April–May 2021. MMWR Morb Mortal Wkly Rep 70:1004–1007. https://doi.org/10.15585/mmwr.mm7028e2
Duan Y, Chen Q (2016) TGF-β1 regulating miR-205/miR-195 expression affects the TGF-β signal pathway by respectively targeting SMAD2/SMAD7. Oncol Rep 36:1837–1844. https://doi.org/10.3892/or.2016.5023
Eastman Q, Grosschedl R (1999) Regulation of LEF-1/TCF transcription factors by Wnt and other signals. Curr Opin Cell Biol 11:233–240. https://doi.org/10.1016/S0955-0674(99)80031-3
Ebrahimpour A, Sarfi M, Rezatabar S, Tehrani SS (2021) Novel insights into the interaction between long non-coding RNAs and microRNAs in glioma. Mol Cell Biochem 476:2317–2335. https://doi.org/10.1007/s11010-021-04080-x
Eichhorn PJA, Rodón L, Gonzàlez-Juncà A et al (2012) USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma. Nat Med 18:429–435. https://doi.org/10.1038/nm.2619
El-Kashef DH, Serrya MS (2019) Sitagliptin ameliorates thioacetamide-induced acute liver injury via modulating TLR4/NF-KB signaling pathway in mice. Life Sci 228:266–273. https://doi.org/10.1016/j.lfs.2019.05.019
Ellisen LW, Bird J, West DC et al (1991) TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 66:649–661. https://doi.org/10.1016/0092-8674(91)90111-B
Fan X, Khaki L, Zhu TS et al (2010) NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells (Dayton, Ohio) 28:5–16. https://doi.org/10.1002/stem.254
Fei F, He Y, He S et al (2018) LncRNA SNHG3 enhances the malignant progress of glioma through silencing KLF2 and p21. Biosci Rep 38:BSR20180420. https://doi.org/10.1042/BSR20180420
Feitelson MA, Zhu M, Duan LX, London WT (1993) Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 8:1109–1117
Feng Y, Huang J, Ding Y et al (2010) Tamoxifen-induced apoptosis of rat C6 glioma cells via PI3K/Akt, JNK and ERK activation. Oncol Rep 24:1561–1567. https://doi.org/10.3892/or_00001018
Ferletta M, Caglayan D, Mokvist L et al (2011) Forced expression of Sox21 inhibits Sox2 and induces apoptosis in human glioma cells. Int J Cancer 129:45–60. https://doi.org/10.1002/ijc.25647
Formosa R, Vassallo J (2014) cAMP signalling in the normal and tumorigenic pituitary gland. Mol Cell Endocrinol 392:37–50. https://doi.org/10.1016/j.mce.2014.05.004
Fortini ME (2009) Notch signaling: the core pathway and its posttranslational regulation. Dev Cell 16:633–647. https://doi.org/10.1016/j.devcel.2009.03.010
Fu J, Rodova M, Nanta R et al (2013) NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200. Neuro-Oncology 15:691–706. https://doi.org/10.1093/neuonc/not011
Furnari FB, Cloughesy TF, Cavenee WK, Mischel PS (2015) Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma. Nat Rev Cancer 15:302–310. https://doi.org/10.1038/nrc3918
Ghafouri-Fard S, Poulet C, Malaise M et al (2021) The emerging role of non-coding RNAs in osteoarthritis. Front Immunol 12:5987. https://doi.org/10.3389/fimmu.2021.773171
González-Gómez P, Crecente-Campo J, Zahonero C et al (2015) Controlled release microspheres loaded with BMP7 suppress primary tumors from human glioblastoma. Oncotarget 6:10950–10963. https://doi.org/10.18632/oncotarget.3459
Grimm D, Bauer J, Wise P et al (2020) The role of SOX family members in solid tumours and metastasis. Semin Cancer Biol 67:122–153. https://doi.org/10.1016/j.semcancer.2019.03.004
Gruszka R, Zakrzewski K, Liberski PP, Zakrzewska M (2020) microRNA interaction with MAPK and AKT pathways in paediatric brain tumours – preliminary results and review of the literature. Folia Neuropathol 58:123–132. https://doi.org/10.5114/fn.2020.96734
Gu J, Li G, Sun T et al (2008) Blockage of the STAT3 signaling pathway with a decoy oligonucleotide suppresses growth of human malignant glioma cells. J Neuro-Oncol 89:9–17. https://doi.org/10.1007/s11060-008-9590-9
Guo G, Gong K, Ali S et al (2017) A TNF-JNK-Axl-ERK signaling axis mediates primary resistance to EGFR inhibition in glioblastoma. Nat Neurosci 20:1074–1084. https://doi.org/10.1038/nn.4584
Guo S-K, Shen M-F, Yao H-W, Liu Y-S (2018) Enhanced expression of TGFBI promotes the proliferation and migration of glioma cells. Cellular Physiol Biochem 49:1097–1109. https://doi.org/10.1159/000493293
Guo C, Liang C, Yang J et al (2019) LATS2 inhibits cell proliferation and metastasis through the Hippo signaling pathway in glioma. Oncol Rep 41:2753–2761. https://doi.org/10.3892/or.2019.7065
Guo Q, Li L, Bo Q et al (2020) Long noncoding RNA PITPNA-AS1 promotes cervical cancer progression through regulating the cell cycle and apoptosis by targeting the miR-876-5p/c-MET axis. Biomed Pharmacother 128:110072. https://doi.org/10.1016/j.biopha.2020.110072
Gürsel DB, Connell-Albert YS, Tuskan RG et al (2011) Control of proliferation in astrocytoma cells by the receptor tyrosine kinase/PI3K/AKT signaling axis and the use of PI-103 and TCN as potential anti-astrocytoma therapies. Neuro-Oncology 13:610–621. https://doi.org/10.1093/neuonc/nor035
Hall PA, McKee PH, Du Menage PH et al (1993) High levels of p53 protein in UV-irradiated normal human skin. Oncogene 8:203–207
Han L, Yuan B, Shimada R et al (2018) Cytocidal effects of arenobufagin and hellebrigenin, two active bufadienolide compounds, against human glioblastoma cell line U-87. Int J Oncol 53:2488–2502. https://doi.org/10.3892/ijo.2018.4567
Harvey M, Sands AT, Weiss RS et al (1993) In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 8:2457–2467
Harvey KF, Zhang X, Thomas DM (2013) The Hippo pathway and human cancer. Nat Rev Cancer 13:246–257. https://doi.org/10.1038/nrc3458
Haupt Y, Maya R, Kazaz A, Oren M (1997) Mdm2 promotes the rapid degradation of p53. Nature 387:296–299. https://doi.org/10.1038/387296a0
Hegi ME, Diserens A-C, Bady P et al (2011) Pathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib--a phase II trial. Mol Cancer Ther 10:1102–1112. https://doi.org/10.1158/1535-7163.MCT-11-0048
Held-Feindt J, Mentlein R (2002) CD70/CD27 ligand, a member of the TNF family, is expressed in human brain tumors. Int J Cancer 98:352–356. https://doi.org/10.1002/ijc.10207
Holmes B, Benavides-Serrato A, Saunders JT et al (2021) mTORC2-mediated direct phosphorylation regulates YAP activity promoting glioblastoma growth and invasive characteristics. Neoplasia (United States) 23:951–965. https://doi.org/10.1016/j.neo.2021.07.005
Hu B, Mao Z, Jiang X et al (2018) Role of TGF-β1/Smad3-mediated fibrosis in drug resistance mechanism of prolactinoma. Brain Res 1698:204–212. https://doi.org/10.1016/j.brainres.2018.07.024
Huang TT, Sarkaria SM, Cloughesy TF, Mischel PS (2009) Targeted therapy for malignant glioma patients: lessons learned and the road ahead. Neurotherapeutics 6:500–512. https://doi.org/10.1016/j.nurt.2009.04.008
Hughes WE, Chabowski DS, Ait-Aissa K et al (2021) Critical interaction between telomerase and autophagy in mediating flow-induced human arteriolar vasodilation. Arterioscler Thromb Vasc Biol 41:446–457. https://doi.org/10.1161/ATVBAHA.120.314944
Hutterer M, Knyazev P, Abate A et al (2008) Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme. Clin Cancer Res 14:130–138. https://doi.org/10.1158/1078-0432.CCR-07-0862
Ikushima H, Todo T, Ino Y et al (2009) Autocrine TGF-β signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors (https://doi.org/10.1016/j.stem.2009.08.018). Cell Stem Cell 5:666. https://doi.org/10.1016/j.stem.2009.11.011
Infante P, Mori M, Alfonsi R et al (2015) Gli1/DNA interaction is a druggable target for Hedgehog-dependent tumors. EMBO J 34:200–217. https://doi.org/10.15252/embj.201489213
Infante P, Malfanti A, Quaglio D et al (2021) Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma. Cancer Lett 499:220–231. https://doi.org/10.1016/j.canlet.2020.11.028
Ingallina C, Costa PM, Ghirga F et al (2017) Polymeric glabrescione B nanocapsules for passive targeting of Hedgehog-dependent tumor therapy. Nanomedicine 12:711–728. https://doi.org/10.2217/nnm-2016-0388
Ippen FM, Alvarez-Breckenridge CA, Kuter BM et al (2019) The dual PI3K/mTOR pathway inhibitor GDC-0084 achieves antitumor activity in PIK3CA-mutant breast cancer brain metastases. Clin Cancer Res 25:3374–3383. https://doi.org/10.1158/1078-0432.CCR-18-3049
Iyer A, Zurolo E, Prabowo A et al (2012) MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory response. PLoS One 7. https://doi.org/10.1371/journal.pone.0044789
Jackson TA, Schweppe RE, Koterwas DM, Bradford AP (2001) Fibroblast growth factor activation of the rat PRL promoter is mediated by PKCdelta. Mol Endocrinol (Baltimore, MD) 15:1517–1528. https://doi.org/10.1210/mend.15.9.0683
Jayaram S, Gupta MK, Raju R et al (2016) Multi-omics data integration and mapping of altered kinases to pathways reveal gonadotropin hormone signaling in glioblastoma. Omics J Integr Biol 20:736–746. https://doi.org/10.1089/omi.2016.0142
Ji W, Liu Y, Xu B et al (2021) Bioinformatics analysis of expression profiles and prognostic values of the signal transducer and activator of transcription family genes in glioma. Front Genet 12. https://doi.org/10.3389/fgene.2021.625234
Jiang Y, He J, Guo Y et al (2020) Identification of genes related to low-grade glioma progression and prognosis based on integrated transcriptome analysis. J Cell Biochem 121:3099–3111. https://doi.org/10.1002/jcb.29577
Kahn M (2014) Can we safely target the WNT pathway? Nat Rev Drug Discov 13:513–532. https://doi.org/10.1038/nrd4233
Kahn SA, Wang X, Nitta RT et al (2018) Notch1 regulates the initiation of metastasis and self-renewal of group 3 medulloblastoma. Nat Commun 9:4121. https://doi.org/10.1038/s41467-018-06564-9
Kalkman HO (2012) A review of the evidence for the canonical Wnt pathway in autism spectrum disorders. Mol Autism 3. https://doi.org/10.1186/2040-2392-3-10
Kanamori M, Kawaguchi T, Nigro JM et al (2007) Contribution of Notch signaling activation to human glioblastoma multiforme. J Neurosurg 106:417–427. https://doi.org/10.3171/jns.2007.106.3.417
Kane PJ, Phipps KP, Harkness WFJ, Hayward RD (1999) Intracranial neoplasms in the first year of life: results of a second cohort of patients from a single institution. Br J Neurosurg 13:294–298. https://doi.org/10.1080/02688699943718
Kant S, Tran KV, Kvandova M et al (2022) PGC1α regulates the endothelial response to fluid shear stress via telomerase reverse transcriptase control of heme oxygenase-1. Arterioscler Thromb Vasc Biol 42:19–34. https://doi.org/10.1161/ATVBAHA.121.317066
Katoh M (2001) Molecular cloning and characterization of MFRP, a novel gene encoding a membrane-type Frizzled-related protein. Biochem Biophys Res Commun 282:116–123. https://doi.org/10.1006/bbrc.2001.4551
Katsushima K, Natsume A, Ohka F et al (2016) Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment. Nat Commun 7:1–14. https://doi.org/10.1038/ncomms13616
Kaur N, Chettiar S, Rathod S et al (2013) Wnt3a mediated activation of Wnt/β-catenin signaling promotes tumor progression in glioblastoma. Mol Cell Neurosci 54:44–57. https://doi.org/10.1016/j.mcn.2013.01.001
Ke XX, Pang Y, Chen K et al (2018) Knockdown of arsenic resistance protein 2 inhibits human glioblastoma cell proliferation through the MAPK/ERK pathway. Oncol Rep 40:3313–3322. https://doi.org/10.3892/or.2018.6777
Keshet Y, Seger R (2010) The MAP kinase signaling cascades: a system of hundreds of components regulates a diverse array of physiological functions. Methods Mol Biol (Clifton, NJ) 661:3–38. https://doi.org/10.1007/978-1-60761-795-2_1
Khalil AM, Guttman M, Huarte M et al (2009) Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A 106:11667–11672. https://doi.org/10.1073/pnas.0904715106
Khan MS, Halagowder D, Devaraj SN (2011) Methylated chrysin induces co-ordinated attenuation of the canonical Wnt and NF-kB signaling pathway and upregulates apoptotic gene expression in the early hepatocarcinogenesis rat model. Chem Biol Interact 193:12–21. https://doi.org/10.1016/j.cbi.2011.04.007
Khanna P, Chua PJ, Bay BH, Baeg GH (2015) The JAK/STAT signaling cascade in gastric carcinoma (review). Int J Oncol 47:1617–1626. https://doi.org/10.3892/ijo.2015.3160
Kim HI, Lee SJ, Choi Y-J et al (2021) Quercetin induces apoptosis in glioblastoma cells by suppressing Axl/IL-6/STAT3 signaling pathway. Am J Chin Med 49:767–784. https://doi.org/10.1142/S0192415X21500361
Kober P, Boresowicz J, Rusetska N et al (2018) DNA methylation profiling in nonfunctioning pituitary adenomas. Mol Cell Endocrinol 473:194–204. https://doi.org/10.1016/j.mce.2018.01.020
Koinuma D, Shinozaki M, Komuro A et al (2003) Arkadia amplifies TGF-β superfamily signalling through degradation of Smad7. EMBO J 22:6458–6470. https://doi.org/10.1093/emboj/cdg632
Komori H, Xiao Q, McCartney BM, Lee C-Y (2014) Brain tumor specifies intermediate progenitor cell identity by attenuating β-catenin/Armadillo activity. Development (Cambridge, England) 141:51–62. https://doi.org/10.1242/dev.099382
Kundu S, Mawhorter M, Merkoulov SM et al (2014) Therapy with bevacizumab is associated with reduced expression of KLF2 in peripheral blood mononuclear cells: a potential prothrombotic mechanism. Blood 124:4254–4254. https://doi.org/10.1182/blood.V124.21.4254.4254
Lakka SS, Jasti SL, Gondi C et al (2002) Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro. Oncogene 21:5601–5608. https://doi.org/10.1038/sj.onc.1205646
Lamour V, Henry A, Kroonen J et al (2015) Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo. Int J Cancer 137:1047–1057. https://doi.org/10.1002/ijc.29454
Larouche V, Huang A, Bartels U, Bouffet E (2007) Tumors of the central nervous system in the first year of life. Pediatr Blood Cancer 49:1074–1082. https://doi.org/10.1002/pbc.21351
Lasky JL, Wu H (2005) Notch signaling, brain development, and human disease. Pediatr Res 57:104R–109R. https://doi.org/10.1203/01.PDR.0000159632.70510.3D
Lasky JL, Choi EJ, Johnston S et al (2008) Congenital brain tumors: case series and review of the literature. J Pediatr Hematol Oncol 30:326–331. https://doi.org/10.1097/MPH.0b013e3181647bf0
Lau GJ (2008) Analysis of naked in the canonical Wnt pathway 136
Lee J-S, Gil J-E, Kim J-H et al (2008) Brain cancer stem-like cell genesis from p53-deficient mouse astrocytes by oncogenic Ras. Biochem Biophys Res Commun 365:496–502. https://doi.org/10.1016/j.bbrc.2007.11.005
Lee S, Qiao J, Paul P et al (2012) FAK is a critical regulator of neuroblastoma liver metastasis. Oncotarget 3:1576–1587. https://doi.org/10.18632/oncotarget.732
Lee K-S, Wu Z, Song Y et al (2013) Roles of PINK1, mTORC2, and mitochondria in preserving brain tumor-forming stem cells in a noncanonical Notch signaling pathway. Genes Dev 27:2642–2647. https://doi.org/10.1101/gad.225169.113
Lee BY, Timpson P, Horvath LG, Daly RJ (2015) FAK signaling in human cancer as a target for therapeutics. Pharmacol Ther 146:132–149. https://doi.org/10.1016/j.pharmthera.2014.10.001
Lee Y-W, Cherng Y-G, Yang S-T et al (2021) Hypoxia induced by cobalt chloride triggers autophagic apoptosis of human and mouse drug-resistant glioblastoma cells through targeting the PI3K-AKT-mTOR signaling pathway. Oxidative Med Cell Longev 2021:5558618. https://doi.org/10.1155/2021/5558618
Lei Q, Gu H, Li L et al (2020) TNIP1-mediated TNF-α/NF-κB signalling cascade sustains glioma cell proliferation. J Cell Mol Med 24:530–538. https://doi.org/10.1111/jcmm.14760
Leiss L, Mutlu E, Øyan A et al (2017) Tumour-associated glial host cells display a stem-like phenotype with a distinct gene expression profile and promote growth of GBM xenografts. BMC Cancer 17:108. https://doi.org/10.1186/s12885-017-3109-8
Levine AJ, Bargonetti J, Bond GL et al (2005) The p53 tumor suppressor pathway and cancer. Springer US, Boston
Li H-F, Kim J-S, Waldman T (2009) Radiation-induced Akt activation modulates radioresistance in human glioblastoma cells. Radiat Oncol (London, England) 4:43. https://doi.org/10.1186/1748-717X-4-43
Li KK-W, Lau K-M, Ng H-K (2013a) Signaling pathway and molecular subgroups of medulloblastoma. Int J Clin Exp Pathol 6:1211–1222
Li Q, Yang J, Yu Q et al (2013b) Associations between single-nucleotide polymorphisms in the PI3K-PTEN-AKT-mTOR pathway and increased risk of brain metastasis in patients with non-small cell lung cancer. Clin Cancer Res 19:6252–6260. https://doi.org/10.1158/1078-0432.CCR-13-1093
Li Z, Liu Q, Li C et al (2015) The role of TGF-β/Smad signaling in dopamine agonist-resistant prolactinomas. Mol Cell Endocrinol 402:64–71. https://doi.org/10.1016/j.mce.2014.12.024
Li J, An G, Zhang M, Ma Q (2016) Long non-coding RNA TUG1 acts as a miR-26a sponge in human glioma cells. Biochem Biophys Res Commun 477:743–748. https://doi.org/10.1016/j.bbrc.2016.06.129
Li B, Wang F, Liu N et al (2017) Astragaloside IV inhibits progression of glioma via blocking MAPK/ERK signaling pathway. Biochem Biophys Res Commun 491:98–103. https://doi.org/10.1016/j.bbrc.2017.07.052
Li L, Yang Y, Wu M et al (2018a) β-asarone induces apoptosis and cell cycle arrest of human glioma U251 cells via suppression of HnRNP A2/B1-mediated pathway in vitro and in vivo. Molecules (Basel, Switzerland) 23. https://doi.org/10.3390/molecules23051072
Li Y, He Z-C, Zhang X-N et al (2018b) Stanniocalcin-1 augments stem-like traits of glioblastoma cells through binding and activating NOTCH1. Cancer Lett 416:66–74. https://doi.org/10.1016/j.canlet.2017.11.033
Li Z, Chen Y, An T et al (2019) Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway. J Exp Clin Cancer Res: CR 38:139. https://doi.org/10.1186/s13046-019-1134-y
Li B, Li Y, Tomkiewicz-Raulet C et al (2020a) Design, synthesis, and biological evaluation of covalent inhibitors of focal adhesion kinase (FAK) against human malignant glioblastoma. J Med Chem 63:12707–12724. https://doi.org/10.1021/acs.jmedchem.0c01059
Li W, Du Q, Li X et al (2020b) Eriodictyol inhibits proliferation, metastasis and induces apoptosis of glioma cells via PI3K/Akt/NF-κB signaling pathway. Front Pharmacol 11:114. https://doi.org/10.3389/fphar.2020.00114
Li X, Tao Z, Wang H et al (2020c) Dual inhibition of Src and PLK1 regulate stemness and induce apoptosis through Notch1-SOX2 signaling in EGFRvIII positive glioma stem cells (GSCs). Exp Cell Res 396:112261. https://doi.org/10.1016/j.yexcr.2020.112261
Li C, Zhou Y, Deng H et al (2021) Mining database for the therapeutic targets and prognostic biomarkers among STAT family in glioblastoma. Cancer Biomark Sect A Dis Markers 30:179–191. https://doi.org/10.3233/CBM-201746
Liang H, Yang X, Liu C et al (2018) Effect of nf-kb signaling pathway on the expression of mif, tnf-α, il-6 in the regulation of intervertebral disc degeneration. J Musculoskelet Neuronal Interact 18:551–556
Lino MM, Merlo A, Boulay JL (2010) Notch signaling in glioblastoma: a developmental drug target? BMC Med 8:1–9. https://doi.org/10.1186/1741-7015-8-72
Litingtung Y, Lei L, Westphal H, Chiang C (1998) Sonic hedgehog is essential to foregut development. Nat Genet 20:58–61. https://doi.org/10.1038/1717
Liu Q, Xu X, Zhao M et al (2015a) Berberine induces senescence of human glioblastoma cells by downregulating the EGFR-MEK-ERK signaling pathway. Mol Cancer Ther 14:355–363. https://doi.org/10.1158/1535-7163.MCT-14-0634
Liu T, Yu H, Ding L et al (2015b) Conditional knockout of telomerase reverse transcriptase in mesenchymal cells impairs mouse pulmonary fibrosis. PLoS One 10:e0142547. https://doi.org/10.1371/journal.pone.0142547
Liu H, Xiong J, He T et al (2017a) High uric acid-induced epithelial-mesenchymal transition of renal tubular epithelial cells via the TLR4/NF-kB signaling pathway. Am J Nephrol 46:333–342
Liu Z, Wang F, Zhou Z-W et al (2017b) Alisertib induces G2/M arrest, apoptosis, and autophagy via PI3K/Akt/mTOR- and p38 MAPK-mediated pathways in human glioblastoma cells. Am J Transl Res 9:845–873
Liu HW, Lee PM, Bamodu OA et al (2019) Enhanced Hsa-mir-181d/p-STAT3 and Hsa-miR-181d/p-STAT5A ratios mediate the anticancer effect of garcinol in STAT3/5A-addicted glioblastoma. Cancers 11:1888. https://doi.org/10.3390/cancers11121888
Liu X, Lu B, Fu J et al (2021) Amorphous silica nanoparticles induce inflammation via activation of NLRP3 inflammasome and HMGB1/TLR4/MYD88/NF-kb signaling pathway in HUVEC cells. J Hazard Mater 404. https://doi.org/10.1016/j.jhazmat.2020.124050
Liu N, Ma X, Wang J et al (2022) Effects of ambient fine particulate matter on oxidative stress, inflammation, and janus kinase/signal transducer and activator of transcription signal molecules: a panel study of asthmatic adults in Taiyuan, China. Air Qual Atmos Health 15:403–414. https://doi.org/10.1007/s11869-021-01139-y
Lo H-W (2010) Targeting Ras-RAF-ERK and its interactive pathways as a novel therapy for malignant gliomas. Curr Cancer Drug Targets 10:840–848. https://doi.org/10.2174/156800910793357970
Lu J, Peng Y, Huang R et al (2021) Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma. BMC Cancer 21:723. https://doi.org/10.1186/s12885-021-08456-6
Luo Z, Wang B, Liu H, Shi L (2020) TNF inhibitor pomalidomide sensitizes glioblastoma cells to EGFR inhibition. Ann Clin Lab Sci 50:474–480
Ma X-L, Shang F, Ni W et al (2018a) MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD1. J Cancer Res Clin Oncol 144:2351–2366. https://doi.org/10.1007/s00432-018-2745-y
Ma Y, Zhou G, Li M et al (2018b) Long noncoding RNA DANCR mediates cisplatin resistance in glioma cells via activating AXL/PI3K/Akt/NF-κB signaling pathway. Neurochem Int 118:233–241. https://doi.org/10.1016/j.neuint.2018.03.011
Mack SC, Singh I, Wang X et al (2019) Chromatin landscapes reveal developmentally encoded transcriptional states that define human glioblastoma. J Exp Med 216:1071–1090. https://doi.org/10.1084/jem.20190196
Mandal T, Bhowmik A, Chatterjee A et al (2014) Reduced phosphorylation of Stat3 at Ser-727 mediated by casein kinase 2 – protein phosphatase 2A enhances Stat3 Tyr-705 induced tumorigenic potential of glioma cells. Cell Signal 26:1725–1734. https://doi.org/10.1016/j.cellsig.2014.04.003
Marigo V, Johnson RL, Vortkamp A, Tabin CJ (1996) Sonic hedgehog differentially regulates expression of GLI and GLI3 during limb development. Dev Biol 180:273–283. https://doi.org/10.1006/dbio.1996.0300
Marjanovic Vicentic J, Drakulic D, Garcia I et al (2019) SOX3 can promote the malignant behavior of glioblastoma cells. Cell Oncol (Dordrecht) 42:41–54. https://doi.org/10.1007/s13402-018-0405-5
Masliantsev K, Karayan-Tapon L, Guichet P-O (2021) Hippo signaling pathway in gliomas. Cell 10. https://doi.org/10.3390/cells10010184
Mason WP, Belanger K, Nicholas G et al (2012) A phase II study of the Ras-MAPK signaling pathway inhibitor TLN-4601 in patients with glioblastoma at first progression. J Neuro-Oncol 107:343–349. https://doi.org/10.1007/s11060-011-0747-6
Masurkar SA, Deogharkar A, Bharambe HS, Shirsat NV (2021) Downregulation of CRX, a Group 3-specific oncogenic transcription factor, inhibits TGF-β/activin signaling in medulloblastoma cells. Biochem Biophys Res Commun 568:76–82. https://doi.org/10.1016/j.bbrc.2021.06.064
Mata DA, Benhamida JK, Lin AL et al (2020) Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3-TACC3 fusions. Acta Neuropathol Commun 8:186. https://doi.org/10.1186/s40478-020-01058-6
Matias D, Dubois LG, Pontes B et al (2019) GBM-derived Wnt3a induces M2-like phenotype in microglial cells through Wnt/β-catenin signaling. Mol Neurobiol 56:1517–1530. https://doi.org/10.1007/s12035-018-1150-5
McCoy MK, Tansey MG (2008) TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflammation 5:45. https://doi.org/10.1186/1742-2094-5-45
McKinney A, Lindberg OR, Engler JR et al (2019) Mechanisms of resistance to EGFR inhibition reveal metabolic vulnerabilities in human GBM. Mol Cancer Ther 18:1565–1576. https://doi.org/10.1158/1535-7163.MCT-18-1330
Meertens L, Labeau A, Dejarnac O et al (2017) Axl mediates ZIKA virus entry in human glial cells and modulates innate immune responses. Cell Rep 18:324–333. https://doi.org/10.1016/j.celrep.2016.12.045
Miao L, Jiang Z, Wang J et al (2019) Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway. Oncol Rep 42:605–614. https://doi.org/10.3892/or.2019.7204
Milde T, Rodriguez FJ, Barnholtz-Sloan JS et al (2021) Reimagining pilocytic astrocytomas in the context of pediatric low-grade gliomas. Neuro-Oncology 23:1634–1646. https://doi.org/10.1093/neuonc/noab138
Morford LA, Elliott LH, Carlson SL et al (1997) T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors. J Immunol (Baltimore, MD: 1950) 159:4415–4425
Morrison DK (2012) MAP kinase pathways. Cold Spring Harb Perspect Biol 4:a011254. https://doi.org/10.1101/cshperspect.a011254
Moustakas A (2002) Smad signalling network. J Cell Sci 115:3355–3356. https://doi.org/10.1242/jcs.115.17.3355
Mueller W, Lass U, Wellmann S et al (2005) Mutation analysis of DKK1 and in vivo evidence of predominant p53-independent DKK1 function in gliomas. Acta Neuropathol 109:314–320. https://doi.org/10.1007/s00401-004-0969-1
Nalla AK, Asuthkar S, Bhoopathi P et al (2010) Suppression of uPAR retards radiation-induced invasion and migration mediated by integrin β1/FAK Signaling in medulloblastoma. PLoS One 5:e13006. https://doi.org/10.1371/journal.pone.0013006
Nam D-H, Jeon H-M, Kim S et al (2008) Activation of notch signaling in a xenograft model of brain metastasis. Clin Cancer Res 14:4059–4066. https://doi.org/10.1158/1078-0432.CCR-07-4039
Nam JH, Cho H, Kang H et al (2017) A mercaptoacetamide-based class II histone deacetylase inhibitor suppresses cell migration and invasion in monomorphic malignant human glioma cells by inhibiting FAK/STAT3 signaling. J Cell Biochem 118:4672–4685. https://doi.org/10.1002/jcb.26133
Nayak L, Bhattacharyya NP, De RK (2016) Wnt signal transduction pathways: modules, development and evolution. BMC Syst Biol 10:197–213. https://doi.org/10.1186/s12918-016-0299-7
Newman EA, Chukkapalli S, Bashllari D et al (2017) Alternative NHEJ pathway proteins as components of MYCN oncogenic activity in human neural crest stem cell differentiation: implications for neuroblastoma initiation. Cell Death Dis 8:3208. https://doi.org/10.1038/s41419-017-0004-9
Ng FS-L, Toh TB, Ting EH-L et al (2012) Progenitor-like traits contribute to patient survival and prognosis in oligodendroglial tumors. Clin Cancer Res 18:4122–4135. https://doi.org/10.1158/1078-0432.CCR-11-3064
Northcott PA, Dubuc AM, Pfister S, Taylor MD (2012) Molecular subgroups of medulloblastoma. Expert Rev Neurother 12:871–884. https://doi.org/10.1586/ern.12.66
Novellasdemunt L, Antas P, Li VSW (2015) Targeting Wnt signaling in colorectal cancer. A review in the theme: cell signaling: proteins, pathways and mechanisms. Am J Physiol Cell Physiol 309:C511–C521. https://doi.org/10.1152/ajpcell.00117.2015
Novodvorsky P, Chico TJA (2014) The role of the transcription factor KLF2 in vascular development and disease. Prog Mol Biol Transl Sci 124:155–188. https://doi.org/10.1016/B978-0-12-386930-2.00007-0
Núñez FJ, Mendez FM, Kadiyala P et al (2019) IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response. Sci Transl Med 11. https://doi.org/10.1126/scitranslmed.aaq1427
Nuñez RE, Del Valle MM, Ortiz K et al (2021) Microglial cytokines induce invasiveness and proliferation of human glioblastoma through pyk2 and fak activation. Cancers 13:6160. https://doi.org/10.3390/cancers13246160
Oi S, Matsumoto S, Choi JU et al (1990) Brain tumors diagnosed in the first year of life in five Far-Eastern countries – statistical analysis of 307 cases. Childs Nerv Syst 6:79–85. https://doi.org/10.1007/BF00307926
Oncogene TG (1999) The Rel/NF-κB signal transduction pathway: introduction. nature.com
Onishi S, Yamasaki F, Nakano Y et al (2018) RELA fusion-positive anaplastic ependymoma: molecular characterization and advanced MR imaging. Brain Tumor Pathol 35:41–45. https://doi.org/10.1007/s10014-017-0301-0
Ouyang T, Meng W, Li M et al (2020) Recent advances of the Hippo/YAP signaling pathway in brain development and glioma. Cell Mol Neurobiol 40:495–510. https://doi.org/10.1007/s10571-019-00762-9
Pai SG, Carneiro BA, Mota JM et al (2017) Wnt/beta-catenin pathway: modulating anticancer immune response. J Hematol Oncol 10:1–12. https://doi.org/10.1186/s13045-017-0471-6
Pan JX (2017) LncRNA H19 promotes atherosclerosis by regulating MAPK and NF-kB signaling pathway. Eur Rev Med Pharmacol Sci 21:322–328
Pathak P, Kumar A, Jha P et al (2017) Genetic alterations related to BRAF-FGFR genes and dysregulated MAPK/ERK/mTOR signaling in adult pilocytic astrocytoma. Brain Pathol (Zurich, Switzerland) 27:580–589. https://doi.org/10.1111/bpa.12444
Pećina-Šlaus N (2010) Wnt signal transduction pathway and apoptosis: a review. Cancer Cell Int 10. https://doi.org/10.1186/1475-2867-10-22
Pećina-Šlaus N, Kafka A, Varošanec AM et al (2016) Expression patterns of Wnt signaling component, secreted frizzled-related protein 3 in astrocytoma and glioblastoma. Mol Med Rep 13:4245–4251. https://doi.org/10.3892/mmr.2016.5061
Petit E, Cartron P-F, Oliver L, Vallette FM (2017) The phosphorylation of Metaxin 1 controls Bak activation during TNFα induced cell death. Cell Signal 30:171–178. https://doi.org/10.1016/j.cellsig.2016.11.008
Phi JH, Park SH, Kim SK et al (2008) Sox2 expression in brain tumors: a reflection of the neuroglial differentiation pathway. Am J Surg Pathol 32:103–112. https://doi.org/10.1097/PAS.0b013e31812f6ba6
Phillips JJ, Huillard E, Robinson AE et al (2012) Heparan sulfate sulfatase SULF2 regulates PDGFRα signaling and growth in human and mouse malignant glioma. J Clin Invest 122:911–922. https://doi.org/10.1172/JCI58215
Phoenix TN, Temple S (2010) Spred1, a negative regulator of Ras-MAPK-ERK, is enriched in CNS germinal zones, dampens NSC proliferation, and maintains ventricular zone structure. Genes Dev 24:45–56. https://doi.org/10.1101/gad.1839510
Plotnikov A, Zehorai E, Procaccia S, Seger R (2011) The MAPK cascades: Signaling components, nuclear roles and mechanisms of nuclear translocation. Biochim Biophys Acta (BBA) Mol Cell Res 1813:1619–1633. https://doi.org/10.1016/j.bbamcr.2010.12.012
Probert L (2015) TNF and its receptors in the CNS: the essential, the desirable and the deleterious effects. Neuroscience 302:2–22. https://doi.org/10.1016/j.neuroscience.2015.06.038
Quatannens D, Verhoeven Y, Van Dam P et al (2022) Targeting hedgehog signaling in pancreatic ductal adenocarcinoma. Pharmacol Ther 236:108107. https://doi.org/10.1016/j.pharmthera.2022.108107
Rankin E, Giaccia A (2016) The receptor tyrosine kinase AXL in cancer progression. Cancers 8:103. https://doi.org/10.3390/cancers8110103
Ravi VM, Neidert N, Will P et al (2022) T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10. Nat Commun 13:925. https://doi.org/10.1038/s41467-022-28523-1
Reichrath S, Müller CSL, Gleissner B et al (2010) Notch- and vitamin D signaling in 1,25(OH)2D3-resistant glioblastoma multiforme (GBM) cell lines. J Steroid Biochem Mol Biol 121:420–424. https://doi.org/10.1016/j.jsbmb.2010.02.028
Reis M, Czupalla CJ, Ziegler N et al (2012) Endothelial Wnt/β-catenin signaling inhibits glioma angiogenesis and normalizes tumor blood vessels by inducing PDGF-B expression. J Exp Med 209:1611–1627. https://doi.org/10.1084/jem.20111580
Rekers NH, Sminia P, Peters GJ (2011) Towards tailored therapy of glioblastoma multiforme. J Chemother (Florence, Italy) 23:187–199. https://doi.org/10.1179/joc.2011.23.4.187
Reudhabibadh R, Binlateh T, Chonpathompikunlert P et al (2021) Suppressing Cdk5 activity by luteolin inhibits MPP+-induced apoptotic of neuroblastoma through Erk/Drp1 and Fak/Akt/GSK3β pathways. Molecules 26:1307. https://doi.org/10.3390/molecules26051307
Rickert CH, Probst-Cousin S, Gullotta F (1997) Primary intracranial neoplasms of infancy and early childhood. Childs Nerv Syst 13:507–513. https://doi.org/10.1007/s003810050127
Robens BK, Gembé E, Fassunke J et al (2016) Abundance of LRP12 C-rs9694676 allelic promoter variant in epilepsy-associated gangliogliomas. Life Sci 155:70–75. https://doi.org/10.1016/j.lfs.2016.01.049
Robinson MH, Maximov V, Lallani S et al (2019) Upregulation of the chromatin remodeler HELLS is mediated by YAP1 in Sonic Hedgehog medulloblastoma. Sci Rep 9:13611. https://doi.org/10.1038/s41598-019-50088-1
Rodriguez-Blanco J, Pednekar L, Penas C et al (2017) Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma. Oncogene 36:6306–6314. https://doi.org/10.1038/onc.2017.232
Roessler E, Belloni E, Gaudenz K et al (1996) Mutations in the human Sonic Hedgehog gene cause holoprosencephaly. Nat Genet 14:357–360. https://doi.org/10.1038/ng1196-357
Rogers HA, Estranero J, Gudka K, Grundy RG (2017) The therapeutic potential of targeting the PI3K pathway in pediatric brain tumors. Oncotarget 8:2083–2095. https://doi.org/10.18632/oncotarget.13781
Runyan CE, Schnaper HW, Poncelet A-C (2005) The role of internalization in transforming growth factor beta1-induced Smad2 association with Smad anchor for receptor activation (SARA) and Smad2-dependent signaling in human mesangial cells. J Biol Chem 280:8300–8308. https://doi.org/10.1074/jbc.M407939200
Sano E, Kazaana A, Tadakuma H et al (2021) Interleukin-6 sensitizes TNF-α and TRAIL/Apo2L dependent cell death through upregulation of death receptors in human cancer cells. Biochim Biophys Acta, Mol Cell Res 1868:119037. https://doi.org/10.1016/j.bbamcr.2021.119037
Sareddy GR, Geeviman K, Ramulu C, Babu PP (2012) The nonsteroidal anti-inflammatory drug celecoxib suppresses the growth and induces apoptosis of human glioblastoma cells via the NF-κB pathway. J Neuro-Oncol 106:99–109. https://doi.org/10.1007/s11060-011-0662-x
Sareddy GR, Pratap UP, Venkata PP et al (2021) Activation of estrogen receptor beta signaling reduces stemness of glioma stem cells. Stem Cells 39:536–550. https://doi.org/10.1002/stem.3337
Satoh T, Nakatsuka D, Watanabe Y et al (2000) Neuroprotection by MAPK/ERK kinase inhibition with U0126 against oxidative stress in a mouse neuronal cell line and rat primary cultured cortical neurons. Neurosci Lett 288:163–166. https://doi.org/10.1016/s0304-3940(00)01229-5
Schieffer B, Luchtefeld M, Braun S et al (2000) Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction. Circ Res 87:1195–1201. https://doi.org/10.1161/01.RES.87.12.1195
Schumann RR, Pfeil D, Freyer D et al (1998) Lipopolysaccharide and pneumococcal cell wall components activate the mitogen activated protein kinases (MAPK) erk-1, erk-2, and p38 in astrocytes. Glia 22:295–305. https://doi.org/10.1002/(SICI)1098-1136(199803)22:3<295::AID-GLIA8>3.0.CO;2-4
Sebzda E, Zou Z, Lee JS et al (2008) Transcription factor KLF2 regulates the migration of naive T cells by restricting chemokine receptor expression patterns. Nat Immunol 9:292–300. https://doi.org/10.1038/ni1565
Seidensticker MJ, Behrens J (2000) Biochemical interactions in the wnt pathway. Biochim Biophys Acta, Mol Cell Res 1495:168–182. https://doi.org/10.1016/S0167-4889(99)00158-5
Sheng J, He X, Yu W et al (2021) p53-targeted lncRNA ST7-AS1 acts as a tumour suppressor by interacting with PTBP1 to suppress the Wnt/β-catenin signalling pathway in glioma. Cancer Lett 503:54–68. https://doi.org/10.1016/j.canlet.2020.12.039
Shi D, Lin B, Lai J et al (2021) Upregulation of CPNE3 suppresses invasion, migration and proliferation of glioblastoma cells through FAK pathway inactivation. J Mol Histol 52:589–596. https://doi.org/10.1007/s10735-021-09966-0
Shih AH, Holland EC (2006) Notch signaling enhances nestin expression in gliomas. Neoplasia (New York, NY) 8:1072–1082. https://doi.org/10.1593/neo.06526
Shim J, Lee JY, Jonus HC et al (2020) YAP-mediated repression of HRK regulates tumor growth, therapy response, and survival under tumor environmental stress in neuroblastoma. Cancer Res 80:4741–4753. https://doi.org/10.1158/0008-5472.CAN-20-0025
Shuai K, Liu B (2003) Regulation of JAK-STAT signalling in the immune system. Nat Rev Immunol 3:900–911. https://doi.org/10.1038/nri1226
Smith JR, Falkenhagen KM, Coupland SE et al (2007) Malignant B cells from patients with primary central nervous system lymphoma express stromal cell-derived factor-1. Am J Clin Pathol 127:633–641. https://doi.org/10.1309/NUQHJ79BHWYD9TAF
Song L, Liu L, Wu Z et al (2012) TGF-β induces miR-182 to sustain NF-κB activation in glioma subsets. J Clin Invest 122:3563–3578. https://doi.org/10.1172/JCI62339
Stockhausen MT, Kristoffersen K, Poulsen HS (2012) Notch signaling and brain tumors. Adv Exp Med Biol 727:289–304. https://doi.org/10.1007/978-1-4614-0899-4_22
Sumithra B, Saxena U, Das AB (2016) Alternative splicing within the Wnt signaling pathway: role in cancer development. Cell Oncol 39:1–13. https://doi.org/10.1007/s13402-015-0266-0
Sun J, Zhang Y, Li B et al (2019) PITPNA-AS1 abrogates the inhibition of miR-876-5p on WNT5A to facilitate hepatocellular carcinoma progression. Cell Death Dis 10:844. https://doi.org/10.1038/s41419-019-2067-2
Sun LW, Kao SH, Yang SF et al (2021) Corosolic acid attenuates the invasiveness of glioblastoma cells by promoting CHIP-mediated AXL degradation and inhibiting GAS6/AXL/JAK axis. Cells 10:2919. https://doi.org/10.3390/cells10112919
Swartling FJ, Ferletta M, Kastemar M et al (2009) Cyclic GMP-dependent protein kinase II inhibits cell proliferation, Sox9 expression and Akt phosphorylation in human glioma cell lines. Oncogene 28:3121–3131. https://doi.org/10.1038/onc.2009.168
Tabatabai R, Linhares Y, Bolos D et al (2017) Targeting the Wnt pathway in cancer: a review of novel therapeutics. Target Oncol 12:623–641. https://doi.org/10.1007/s11523-017-0507-4
Tan C, Dai Y, Liu X et al (2020) STAT5A induced LINC01198 promotes proliferation of glioma cells through stabilizing DGCR8. Aging 12:5675–5692. https://doi.org/10.18632/aging.102938
Tanaka M, Siemann DW (2020) Gas6/Axl signaling pathway in the tumor immune microenvironment. Cancers 12:1–14. https://doi.org/10.3390/cancers12071850
Tang T, Wang L-X, Yang M-L, Zhang R-M (2020) lncRNA TPTEP1 inhibits stemness and radioresistance of glioma through miR-106a-5p-mediated P38 MAPK signaling. Mol Med Rep 22:4857–4867. https://doi.org/10.3892/mmr.2020.11542
Tao S, Liu M, Shen D et al (2018) TGF-β/Smads signaling affects radiation response and prolongs survival by regulating DNA repair genes in malignant glioma. DNA Cell Biol 37:909–916. https://doi.org/10.1089/dna.2018.4310
Tateishi K, Nakamura T, Juratli TA et al (2019) PI3K/AKT/mTOR pathway alterations promote malignant progression and xenograft formation in oligodendroglial tumors. Clin Cancer Res 25:4375–4387. https://doi.org/10.1158/1078-0432.CCR-18-4144
Tezcan G, Garanina EE, Alsaadi M et al (2021) Therapeutic potential of pharmacological targeting NLRP3 inflammasome complex in cancer. Front Immunol 11:3734. https://doi.org/10.3389/fimmu.2020.607881
Tian Z, Shen J, Wang F et al (2011) Cambogin is preferentially cytotoxic to cells expressing PDGFR. PLoS One 6:e21370. https://doi.org/10.1371/journal.pone.0021370
Tian S, Liu W, Pan Y, Zhan S (2019) Long non-coding RNA Linc00320 inhibits glioma cell proliferation through restraining Wnt/β-catenin signaling. Biochem Biophys Res Commun 508:458–464. https://doi.org/10.1016/j.bbrc.2018.11.101
Toshiyuki M, Reed JC (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293–299. https://doi.org/10.1016/0092-8674(95)90412-3
Tulina N, Matunis E (2001) Control of stem cell self-renewal in Drosophila spermatogenesis by JAK-STAT signaling. Science 294:2546–2549. https://doi.org/10.1126/science.1066700
Vassallo I, Zinn P, Lai M et al (2016) WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1. Oncogene 35:12–21. https://doi.org/10.1038/onc.2015.61
Villarino AV, Kanno Y, Ferdinand JR, O’Shea JJ (2015) Mechanisms of Jak/STAT signaling in immunity and disease. J Immunol 194:21–27. https://doi.org/10.4049/jimmunol.1401867
Vlad A, Röhrs S, Klein-Hitpass L, Müller O (2008) The first five years of the Wnt targetome. Cell Signal 20:795–802. https://doi.org/10.1016/j.cellsig.2007.10.031
Voelzke WR, Petty WJ, Lesser GJ (2008) Targeting the epidermal growth factor receptor in high-grade astrocytomas. Curr Treat Options in Oncol 9:23–31. https://doi.org/10.1007/s11864-008-0053-5
Wagner EF, Nebreda ÁR (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9:537–549. https://doi.org/10.1038/nrc2694
Wan Y, Li X, Slevin E et al (2022) Endothelial dysfunction in pathological processes of chronic liver disease during aging. FASEB J 36:e22125. https://doi.org/10.1096/fj.202101426R
Wang YH, Maurer RA (1999) A role for the mitogen-activated protein kinase in mediating the ability of thyrotropin-releasing hormone to stimulate the prolactin promoter. Mol Endocrinol (Baltimore, MD) 13:1094–1104. https://doi.org/10.1210/mend.13.7.0315
Wang J, Wang C, Meng Q et al (2012) siRNA targeting Notch-1 decreases glioma stem cell proliferation and tumor growth. Mol Biol Rep 39:2497–2503. https://doi.org/10.1007/s11033-011-1001-1
Wang Q, Wang J-Y, Zhang X-P et al (2013) RLIP76 is overexpressed in human glioblastomas and is required for proliferation, tumorigenesis and suppression of apoptosis. Carcinogenesis 34:916–926. https://doi.org/10.1093/carcin/bgs401
Wang Z, Zhang Q, Duan Y et al (2015) TGF-β induced miR-132 enhances the activation of TGF-β signaling through inhibiting SMAD7 expression in glioma cells. Biochem Biophys Res Commun 463:187–192. https://doi.org/10.1016/j.bbrc.2015.05.001
Wang Y, Hou H, Li M et al (2016a) Anticancer effect of eupatilin on glioma cells through inhibition of the Notch-1 signaling pathway. Mol Med Rep 13:1141–1146. https://doi.org/10.3892/mmr.2015.4671
Wang Z-Y, Xiong J, Zhang S-S et al (2016b) Up-regulation of microRNA-183 promotes cell proliferation and invasion in glioma by directly targeting NEFL. Cell Mol Neurobiol 36:1303–1310. https://doi.org/10.1007/s10571-016-0328-5
Wang J, Liu Q, Gao H et al (2017) EGFL7 participates in regulating biological behavior of growth hormone-secreting pituitary adenomas via Notch2/DLL3 signaling pathway. Tumour Biol 39:1010428317706203. https://doi.org/10.1177/1010428317706203
Wang Q, Xu B, Du J et al (2018a) MicroRNA-139-5p/Flt1/Wnt/β-catenin regulatory crosstalk modulates the progression of glioma. Int J Mol Med 41:2139–2149. https://doi.org/10.3892/ijmm.2018.3439
Wang S-J, Wang H, Zhao C-D, Li R (2018b) Long noncoding RNA LINC01426 promotes glioma progression through PI3K/AKT signaling pathway and serves as a prognostic biomarker. Eur Rev Med Pharmacol Sci 22:6358–6368. https://doi.org/10.26355/eurrev_201810_16047
Wang Y, Liu X, Guan G et al (2019) Identification of a five-pseudogene signature for predicting survival and its ceRNA network in glioma. Front Oncol 9:1059. https://doi.org/10.3389/fonc.2019.01059
Wang J, Xia X, Tao X et al (2021) Knockdown of carbohydrate sulfotransferase 12 decreases the proliferation and mobility of glioblastoma cells via the WNT/β-catenin pathway. Bioengineered 12:3934–3946. https://doi.org/10.1080/21655979.2021.1944455
Wang QW, Lin WW, Zhu YJ (2022) Comprehensive analysis of a TNF family based-signature in diffuse gliomas with regard to prognosis and immune significance. Cell Commun Signal 20:1–15. https://doi.org/10.1186/s12964-021-00814-y
Wechsler-Reya RJ, Scott MP (1999) Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog. Neuron 22:103–114. https://doi.org/10.1016/S0896-6273(00)80682-0
Wetmore C, Eberhart DE, Curran T (2000) The normal patched allele is expressed in medulloblastomas from mice with heterozygous germ-line mutation of patched. Cancer Res 60:2239–2246
Wolter M, Scharwächter C, Reifenberger J et al (2003) Absence of detectable alterations in the putative tumor suppressor gene BTRC in cerebellar medulloblastomas and cutaneous basal cell carcinomas. Acta Neuropathol 106:287–290. https://doi.org/10.1007/s00401-003-0745-7
Wu J, Wang R, Kan X et al (2022) A Sonic Hedgehog-Gli-Bmi1 signaling pathway plays a critical role in p27 deficiency induced bone anabolism. Int J Biol Sci 18:956–969. https://doi.org/10.7150/ijbs.65954
Xia X, Wang X, Cheng Z et al (2019) The role of pyroptosis in cancer: pro-cancer or pro-“host”? Cell Death Dis 10:1–13. https://doi.org/10.1038/s41419-019-1883-8
Xiao Q, Dong M, Cheng F et al (2018) LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling. Int J Oncol 53:1069–1082. https://doi.org/10.3892/ijo.2018.4482
Xiao Z, Liang J, Deng Q et al (2021) Pimozide augments bromocriptine lethality in prolactinoma cells and in a xenograft model via the STAT5/cyclin D1 and STAT5/Bcl-xL signaling pathways. Int J Mol Med 47:113–124. https://doi.org/10.3892/ijmm.2020.4784
Xie H, Yuan C, Ding XH et al (2021a) Identification of key genes and pathways associated with resting mast cells in meningioma. BMC Cancer 21:1–12. https://doi.org/10.1186/s12885-021-08931-0
Xie H, Yuan C, Li J et al (2021b) Potential molecular mechanism of TNF superfamily-related genes in glioblastoma multiforme based on transcriptome and epigenome. Front Neurol 12:44. https://doi.org/10.3389/fneur.2021.576382
Xuan C, Jin M, Wang L et al (2020) PART1 and hsa-miR-429-mediated SHCBP1 expression is an independent predictor of poor prognosis in glioma patients. Biomed Res Int 2020:1767056. https://doi.org/10.1155/2020/1767056
Yahyanejad S, King H, Iglesias VS et al (2016) NOTCH blockade combined with radiation therapy and temozolomide prolongs survival of orthotopic glioblastoma. Oncotarget 7:41251–41264. https://doi.org/10.18632/oncotarget.9275
Yang F, Nam S, Brown CE et al (2014) A novel berbamine derivative inhibits cell viability and induces apoptosis in cancer stem-like cells of human glioblastoma, via up-regulation of miRNA-4284 and JNK/AP-1 signaling. PLoS One 9:e94443. https://doi.org/10.1371/journal.pone.0094443
Yang J, Zhang J-N, Chen W-L et al (2017) Effects of AQP5 gene silencing on proliferation, migration and apoptosis of human glioma cells through regulating EGFR/ERK/p38 MAPK signaling pathway. Oncotarget 8:38444–38455. https://doi.org/10.18632/oncotarget.16461
Yao W, Gong H, Mei H et al (2021) Taxifolin targets PI3K and mTOR and inhibits glioblastoma multiforme. J Oncol 2021:5560915. https://doi.org/10.1155/2021/5560915
Yarza R, Vela S, Solas M, Ramirez MJ (2016) c-Jun N-terminal Kinase (JNK) signaling as a therapeutic target for Alzheimer’s disease. Front Pharmacol 6:321. https://doi.org/10.3389/fphar.2015.00321
Yoshimura A, Naka T, Kubo M (2007) SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 7:454–465. https://doi.org/10.1038/nri2093
Young TL, Matsuda T, Cepko CL (2005) The noncoding RNA taurine upregulated gene 1 is required for differentiation of the murine retina. Curr Biol 15:501–512. https://doi.org/10.1016/j.cub.2005.02.027
Yuan J, Dong X, Yap J, Hu J (2020) The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy. J Hematol Oncol 13:113. https://doi.org/10.1186/s13045-020-00949-4
Zambetti GP (2005) The p53 tumor suppressor pathway and cancer. Springer US, Boston
Zhang W, Liu HT (2002) MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 12:9–18. https://doi.org/10.1038/sj.cr.7290105
Zhang S, Çagatay T, Amanai M et al (2007) Viable mice with compound mutations in the Wnt/Dvl pathway antagonists nkd1 and nkd2. Mol Cell Biol 27:4454–4464. https://doi.org/10.1128/mcb.00133-07
Zhang N, Lin J, Chen J et al (2013) MicroRNA 375 mediates the signaling pathway of corticotropin-releasing factor (CRF) regulating pro-opiomelanocortin (POMC) expression by targeting mitogen-activated protein kinase 8. J Biol Chem 288:10361–10373. https://doi.org/10.1074/jbc.M112.425504
Zhang H, Geng D, Gao J et al (2016a) Expression and significance of Hippo/YAP signaling in glioma progression. Tumor Biol 37:15665–15676. https://doi.org/10.1007/s13277-016-5318-1
Zhang Z, Ren X, Lu X et al (2016b) GZD856, a novel potent PDGFRα/β inhibitor, suppresses the growth and migration of lung cancer cells in vitro and in vivo. Cancer Lett 375:172–178. https://doi.org/10.1016/j.canlet.2016.02.017
Zhang P, Chen X-B, Ding B-Q et al (2018) Down-regulation of ABCE1 inhibits temozolomide resistance in glioma through the PI3K/Akt/NF-κB signaling pathway. Biosci Rep 38. https://doi.org/10.1042/BSR20181711
Zhang D, Zhou H, Liu J, Mao J (2019a) Long noncoding RNA ASB16-AS1 promotes proliferation, migration, and invasion in glioma cells. Biomed Res Int:5437531. https://doi.org/10.1155/2019/5437531
Zhang L, Zhu Y, Cheng H et al (2019b) The increased expression of estrogen-related receptor α correlates with Wnt5a and poor prognosis in patients with glioma. Mol Cancer Ther 18:173–184. https://doi.org/10.1158/1535-7163.MCT-17-0782
Zhang H, Zhu H, Deng G et al (2020) PLEKHA5 regulates tumor growth in metastatic melanoma. Cancer 126:1016–1030. https://doi.org/10.1002/cncr.32611
Zhang A, Xu Y, Xu H et al (2021a) Lactate-induced M2 polarization of tumor-associated macrophages promotes the invasion of pituitary adenoma by secreting CCL17. Theranostics 11:3839–3852. https://doi.org/10.7150/thno.53749
Zhang R, Yang F, Fan H et al (2021b) Long non-coding RNA TUG1/microRNA-187-3p/TESC axis modulates progression of pituitary adenoma via regulating the NF-κB signaling pathway. Cell Death Dis 12:524. https://doi.org/10.1038/s41419-021-03812-7
Zhao Y, Xiao A, Dipierro CG et al (2008) H-Ras increases urokinase expression and cell invasion in genetically modified human astrocytes through Ras/Raf/MEK signaling pathway. Glia 56:917–924. https://doi.org/10.1002/glia.20667
Zhao B, Tumaneng K, Guan KL (2011) The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol 13:877–883. https://doi.org/10.1038/ncb2303
Zhao H-F, Wang J, Tony To S-S (2015a) The phosphatidylinositol 3-kinase/Akt and c-Jun N-terminal kinase signaling in cancer: Alliance or contradiction? (Review). Int J Oncol 47:429–436. https://doi.org/10.3892/ijo.2015.3052
Zhao P, Li Q, Shi Z et al (2015b) GSK-3β regulates tumor growth and angiogenesis in human glioma cells. Oncotarget 6:31901–31915. https://doi.org/10.18632/oncotarget.5043
Zhao Z, Wang B, Hao J et al (2018) Downregulation of the long non-coding RNA taurine-upregulated gene 1 inhibits glioma cell proliferation and invasion and promotes apoptosis. Oncol Lett 15:4026–4032. https://doi.org/10.3892/ol.2018.7784
Zhao B, Ye X, Yang Y et al (2022) Knockdown of ER-α36 expression inhibits glioma proliferation, invasion and epithelial-to-mesenchymal transition. Anat Rec 305:321–332. https://doi.org/10.1002/ar.24723
Zheng Z, Zhang Y, Zhang Z et al (2017) Effect of miR-106b on invasiveness of pituitary adenoma via PTEN-PI3K/AKT. Med Sci Monit 23:1277–1285. https://doi.org/10.12659/msm.900092
Zhou X, Hua L, Zhang W et al (2012) FRK controls migration and invasion of human glioma cells by regulating JNK/c-Jun signaling. J Neuro-Oncol 110:9–19. https://doi.org/10.1007/s11060-012-0933-1
Zhu T, Xu Y, Dong B et al (2011) β-elemene inhibits proliferation of human glioblastoma cells through the activation of glia maturation factor β and induces sensitization to cisplatin. Oncol Rep 26:405–413. https://doi.org/10.3892/or.2011.1276
Zhu Y-G, Lv Y-X, Guo C-Y et al (2021) Harmine inhibits the proliferation and migration of glioblastoma cells via the FAK/AKT pathway. Life Sci 270:119112. https://doi.org/10.1016/j.lfs.2021.119112
Zmeškalová A, Popelová A, Exnerová A et al (2020) Cellular signaling and anti-apoptotic effects of prolactin-releasing peptide and its Analog on SH-SY5Y cells. Int J Mol Sci 21:6343. https://doi.org/10.3390/ijms21176343
Zong Z, Song Y, Xue Y et al (2019) Knockdown of LncRNA SCAMP1 suppressed malignant biological behaviours of glioma cells via modulating miR-499a-5p/LMX1A/NLRC5 pathway. J Cell Mol Med 23:5048–5062. https://doi.org/10.1111/jcmm.14362
Acknowledgments
None
Compliance with Ethical Standards
The authors declare that there is no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Akhlaghdoust, M., Tavakolpour, S., Davoodi, P., Rahmani, S., Zali, A., Rezaei, N. (2022). Signaling Pathways in Neurological Cancers. In: Interdisciplinary Cancer Research. Springer, Cham. https://doi.org/10.1007/16833_2022_14
Download citation
DOI: https://doi.org/10.1007/16833_2022_14
Published:
Publisher Name: Springer, Cham